Background
AMR is one of the top global health threats facing humanity, estimated to directly cause of 1.27 million deaths each year, a devastating number equaling the total combined deaths from HIV and Malaria. But the implications of AMR go beyond health, it affects humans, animals, crops, and the environment. In 2016, the World Bank estimated that by 2050, AMR may result in a further 28 million people living in poverty, a 7.5% decline in global livestock production, a 3.8% reduction in global exports, and 1 trillion USD in additional healthcare costs. However, despite the evident AMR crisis, recognition of the threat and action to mitigate it remains dangerously dwarfed by the scale of the issue.
The event
To bridge the gap between evidence and action, the Global Leaders Group on Antimicrobial Resistance (GLG) and the European Society of Clinical Microbiology and Infectious Disease (ESCMID) will co-host an event to strengthen the links between research, policy, and practice, generate sustainable solutions, and inspire a broader cross-sectoral research agenda.
The event will feature several high-level keynote speakers, including:
• HRH Crown Princess Mary of Denmark
• H.E. Mia Amor Mottley, Prime Minister of Barbados and Chair of the GLG
• H.E. Sophie Løhde, Minister of the Interior and Health of Denmark
• Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization
Keynote addresses will be followed by two panels where multi-disciplinary experts will explore the following pressing questions:
- What lessons have we learnt from COVID-19? Including enhancing AMR prevention efforts, handling misinformation, increasing public awareness, and planning for future pandemics that could further exacerbate AMR.
- What is the critical role of diagnostics in AMR mitigation? Including utilizing the One Health concept, the links between human and animal antimicrobial use and AMR and the need for personalized care for AMR infections to ensure optimal antibiotic use without driving resistance.